Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients (ALOSS)
Teen loss is not uncommon. Depression, emptiness, disbelief, hopelessness, and guilt are typical responses. How teens with cancer cope with the loss of a loved one or a close friend has not been well-studied in the bereavement or oncology literature. This study will describe the impact of loss on teen patients who are on treatment or have recently completed treatment for malignancy. We will look at baseline personality traits and ask teens to identify losses in their life. We will ask questions about coping and meaning-making after loss. A parent will be invited to participate -to measure parental awareness of teen loss and determine if parental coping affects teen coping. The inventories have been validated by other researchers.
Adolescent Oncology Patients
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients|
- Number of participants who have experienced the death of a friend or relative by type of loss. [ Time Frame: Once on Day 1 ] [ Designated as safety issue: No ]The prevalence of loss among the participants will be calculated. The type of losses will be described.
- Descriptive statistics of coping efficacy scores, psychological distress scores, meaning-making scores, and complicated bereavement scores. [ Time Frame: Once on Day 1 ] [ Designated as safety issue: No ]All data for this objective will be mainly analyzed in a descriptive manner. The score for coping efficacy will be calculated from the General Coping Efficacy instrument. In addition, a subset of participants who identify losing a friend to cancer will be invited to complete a 30-45 minute semi-structured interview.
- Number of parents with knowledge of losses experienced by adolescent child. [ Time Frame: Once on Day 1 ] [ Designated as safety issue: No ]Descriptive analysis from the Bereavement Questionnaire (parent version).
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||June 2016|
|Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
All participants will asked to complete a bereavement questionnaire quantifying the losses they have experienced. All participants will be screened for depression/anxiety as well as life outlook using validated tools. Patients who identify that they have experienced the loss of someone significant in their life on the bereavement questionnaire will continue with the study and complete a battery of validated psychological inventories. They will be asked to identify their most significant loss in regards to completion of the remainder of the questionnaire. In addition, those who identify losing a friend to cancer will be invited to participate in a 30-45 minute semi-structured interview (in person or via telephone) during a second session with the study staff. This interview will be audiotaped, to allow for transcription and analysis later. Parents will complete demographic information, the bereavement questionnaire, and complete inventories of family coping / cohesion regardless of child's responses to bereavement questionnaire.
In addition, those who identify losing a friend to cancer will be invited to participate in a 30-45 minute semi-structured interview (in person or via telephone) during a second session with the study staff.
- Estimate the prevalence of loss, with particular interest in the extent of peer loss, in adolescent oncology patients who have been on therapy ≥ 12 months (≥ 6 months if progressive or refractory disease) or off therapy for ≤ 3 years.
- Describe the impact of loss on adolescent oncology patients by focusing on coping efficacy, psychological distress, meaning-making, and complicated bereavement.
- Describe parental knowledge of losses experienced by an adolescent child who has recently undergone therapy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01473862
|United States, Tennessee|
|St. Jude Children's Research Hospital|
|Memphis, Tennessee, United States, 38105|
|Principal Investigator:||Liza Johnson, MD,MPH||St. Jude Children's Research Hospital|